Mattias entered the IP profession in 2015. After completing his M.Sc. and Ph.D. within inflammation, diabetes, and druggable targets from the University of Copenhagen he joined a Danish private practice, and has also worked for a leading UK based IP firm before joining aera.
He works with large international clients primarily in pharma and biotechnology, as well as with universities and start-ups.
Clients appreciate his attention to details and his ability to maintain the focus on the commercial value on innovation.